Written by Contributing Author, Charles Wekesa
One of the most contentious issues in the U.S. rejection is the potential impact on abortion policy. The WHO has repeatedly declared abortion an “essential” component of reproductive healthcare and has called for the removal of legal restrictions such as mandatory waiting periods, third-party authorizations, and criminal penalties. Pro-life policymakers fear that the vague terminology embedded in the amendments could allow international pressure—or even indirect enforcement—to erode pro-life laws in the United States.
The Trump administration has delivered a decisive rejection of the 2024 amendments to the World Health Organization’s International Health Regulations (IHR), declaring that the measures pose unacceptable risks to U.S. sovereignty, constitutional freedoms, and pro-life protections. The decision, announced on July 18, 2025, through a joint statement by Secretary of State Marco Rubio and Secretary of Health and Human Services Robert F. Kennedy Jr., comes at a critical juncture in global health governance. The amendments, adopted by the World Health Assembly in June 2024, were designed to strengthen international responses to pandemics and other public health emergencies. However, the administration argues that the new rules carry vague language, expanded WHO authority, and policy priorities that could undermine domestic laws—particularly those concerning abortion.
At the heart of the dispute is the balance between international cooperation in health emergencies and the preservation of national decision-making. The International Health Regulations, first adopted in 1969 and last updated in 2005, are intended to help countries prevent and respond to cross-border public health threats. The 2024 amendments would have granted the WHO greater authority to declare pandemic emergencies, facilitate “equitable access” to vaccines and other medical commodities, and coordinate international responses more directly. While supporters claim these changes would close dangerous gaps revealed during the COVID-19 crisis, critics in the U.S. government see them as a gateway for political overreach by a body whose leadership is not accountable to the American public.
One of the most contentious issues in the U.S. rejection is the potential impact on abortion policy. The WHO has repeatedly declared abortion an “essential” component of reproductive healthcare and has called for the removal of legal restrictions such as mandatory waiting periods, third-party authorizations, and criminal penalties. Pro-life policymakers fear that the vague terminology embedded in the amendments could allow international pressure—or even indirect enforcement—to erode pro-life laws in the United States. Rubio stated that the administration would “put Americans first in all our actions” and refuse to “tolerate international policies that infringe on Americans’ speech, privacy, or personal liberties.” This statement reflects the administration’s belief that global health cooperation should never be a backdoor for reshaping U.S. law on morally charged issues.
Robert F. Kennedy Jr., speaking in a video message posted on X, framed the issue in terms of civil liberties. He warned that the amendments “open the door to the kind of narrative management, propaganda, and censorship that we saw during the COVID pandemic.” Kennedy emphasized that while the U.S. is willing to work with other nations in times of crisis, it must do so “without undermining our Constitution” or surrendering “America’s treasured sovereignty.” This rhetoric resonates strongly with those who believe that public health emergencies have, in recent years, been used to justify excessive government intrusion into personal freedoms.
Another major factor in the rejection is the administration’s criticism of the process by which the amendments were adopted. According to U.S. officials, there was insufficient opportunity for public input or congressional oversight before the amendments were finalized. While WHO member states, including the U.S., had been involved in discussions since 2022, the Trump administration contends that the final text did not adequately address its concerns. Critics of the U.S. decision argue that this was a missed opportunity for America to shape the rules from within, but the administration maintains that rejecting the amendments outright was the only way to safeguard national interests.
The timing of this decision is also significant. In January 2025, President Trump signed an executive order initiating the U.S. withdrawal from the WHO, with the process expected to be completed by January 2026. Even with the withdrawal underway, the United States would have been bound by the new IHR provisions unless it formally rejected them before July 19, 2025. By acting on July 18, the administration ensured that the amendments would not apply to the U.S., even after they take effect for other countries. This marks another step in the administration’s broader effort to distance the United States from multilateral health agreements it views as compromising sovereignty.
From the WHO’s perspective, the U.S. decision is a setback for global health preparedness. WHO Director-General Tedros Adhanom Ghebreyesus has defended the amendments, insisting they do not give the WHO power to override national laws. Instead, he says, the changes are intended to improve coordination, transparency, and equitable distribution of medical resources during crises. Tedros maintains that the WHO operates on the principle of cooperation and that ultimate authority always rests with individual governments. Many member states have welcomed the amendments, seeing them as essential to avoiding the delays and inequities that plagued the COVID-19 response.
However, the Trump administration remains unconvinced, particularly over provisions related to digital health documentation. Critics argue that such systems—often described as “vaccine passports” or digital IDs—could evolve into tools for global medical surveillance, tracking individuals’ health status, and restricting movement based on compliance with certain medical protocols. While the WHO presents these measures as tools for efficiency and safety, opponents see them as potential threats to privacy and autonomy. The administration’s rejection signals its unwillingness to participate in any mandatory global framework of this kind.
For the pro-life movement in the U.S., the rejection is being hailed as a major victory. Activists have long argued that international health agreements often embed language and standards that promote abortion access worldwide, even in countries where it conflicts with local laws and cultural values. They believe the WHO’s advocacy could one day be leveraged in legal challenges or diplomatic negotiations aimed at weakening state-level abortion restrictions. By rejecting the amendments, the Trump administration has reassured these groups that it will not cede ground in this area to international institutions.
On the other hand, public health experts warn that the decision could leave the U.S. more isolated during future health crises. The IHR framework is one of the few legally binding tools for coordinating international health responses, and the absence of U.S. participation could weaken the system’s effectiveness. They note that pandemics do not respect national borders and that information-sharing and coordinated action are essential to protecting populations. While the U.S. has its sophisticated public health infrastructure, its withdrawal from the WHO and rejection of the IHR amendments could complicate cooperation with other nations.
Ultimately, the rejection of the 2024 IHR amendments underscores a fundamental philosophical divide over the role of global governance in health policy. For the Trump administration and its supporters, the priority is to ensure that no international body—no matter how well-intentioned—can dictate terms that affect American freedoms, laws, or values. For the WHO and its allies, the emphasis is on building stronger global systems that can act swiftly and fairly in emergencies, even if that means asking member states to align with certain shared standards.
The decision reflects a continuation of the “America First” approach that has characterized the administration’s foreign policy. It sends a clear message that the United States will engage with the world on its terms, particularly in areas where moral and constitutional issues are at stake. Whether this approach will leave the country better protected or more vulnerable in the face of future pandemics remains an open question. What is certain is that the debate over sovereignty, global cooperation, and health policy will intensify in the years ahead, especially as the U.S. approaches the completion of its withdrawal from the WHO in 2026.
The Trump administration’s rejection of the 2024 WHO International Health Regulations amendments reflects deeper tensions between global governance and national sovereignty. Officials argue that the IHR’s vague language and expanded mandates could undermine pro-life laws and erode constitutional rights. We at Every Black Life Matters join this critique from a culturally specific vantage point—warning that WHO’s reproductive advocacy threatens Black communities and unborn life within the U.S. The administration’s move underscores a broader posture: resisting external pressure on domestic health policy and reaffirming that international public health measures must not override American legal and moral frameworks—even under the guise of global solidarity.
Source Article
https://www.lifenews.com/2025/07/28/trump-rejects-who-measures-that-threaten-pro-life-laws/